BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Johnson and Johnson
Chinese Patent Office

Generated: December 13, 2017

DrugPatentWatch Database Preview

TEMAZEPAM Drug Profile

« Back to Dashboard

When do Temazepam patents expire, and what generic alternatives are available?

Temazepam is a drug marketed by Actavis Elizabeth, Amneal Pharms, Duramed Pharms Barr, Mylan, Novel Labs Inc, Prinston Inc, Sandoz, Sun Pharm Industries, Usl Pharma, and Watson Labs. and is included in nineteen NDAs.

The generic ingredient in TEMAZEPAM is temazepam. There are seven drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the temazepam profile page.
Drug patent expirations by year for TEMAZEPAM

Pharmacology for TEMAZEPAM

Drug ClassBenzodiazepine

Medical Subject Heading (MeSH) Categories for TEMAZEPAM

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Watson LabsTEMAZEPAMtemazepamCAPSULE;ORAL071447-001May 21, 1993DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Usl PharmaTEMAZEPAMtemazepamCAPSULE;ORAL070490-001Jul 7, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Watson LabsTEMAZEPAMtemazepamCAPSULE;ORAL070383-001Mar 23, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Actavis ElizabethTEMAZEPAMtemazepamCAPSULE;ORAL071620-002Aug 7, 1987ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Prinston IncTEMAZEPAMtemazepamCAPSULE;ORAL201781-002Jun 4, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sun Pharm IndustriesTEMAZEPAMtemazepamCAPSULE;ORAL071174-001Jul 10, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Duramed Pharms BarrTEMAZEPAMtemazepamCAPSULE;ORAL071708-001Sep 29, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Amneal PharmsTEMAZEPAMtemazepamCAPSULE;ORAL203482-002May 23, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
MylanTEMAZEPAMtemazepamCAPSULE;ORAL070920-001Jul 10, 1986ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Prinston IncTEMAZEPAMtemazepamCAPSULE;ORAL201781-004Jun 4, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: